New rapid test could transform iron treatment worldwide
Iron deficiency is one of the world's most common nutritional disorders, affecting millions of women and children globally. Yet diagnosing it remains difficult in many low-resource settings, where access to laboratories and trained health care workers is limited.
Iron deficiency, a prevalent nutritional disorder affecting millions of women and children worldwide, often goes undiagnosed in low-resource settings due to limited access to laboratories and trained healthcare professionals. A new rapid test developed by the Walter and Eliza Hall Institute (WEHI) aims to address this challenge.
Utilizing a simple finger-prick blood sample, the test delivers accurate results at the point of care, eliminating the need for specialized laboratory equipment and enabling rapid diagnosis. Co-developed by Dr. Emily Eriksson, Professor David Anderson, and Huy Van, the test can be administered by a wide range of healthcare professionals, removing the requirement for extensive training.
Dr. Ricardo Ataide, who will lead the field validation and implementation, highlights the test's ability to measure ferritin—the gold-standard biomarker for iron deficiency—immediately, providing a clear visual reference at the clinically important threshold of 30 ng/mL. This feature enables healthcare workers to confidently identify iron deficiency and initiate timely treatment, potentially improving outcomes for millions of women and babies across the globe.
The test could address a critical gap in maternal health programs by identifying women who would most benefit from iron infusions, ensuring limited resources are used effectively. Field validation trials are planned in Malawi and Kenya, with the test expected to pave the way for regulatory approval and global distribution.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
